🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
StemCyte International, Ltd. (TPE:4178)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.75
-1.05 (-7.61%)
At close: Nov 20, 2026

StemCyte International Revenue

StemCyte International had revenue of 95.10M TWD in the quarter ending September 30, 2026, with 12.68% growth. This brings the company's total for the last twelve months to 376.29M, down -0.50% year-over-year. In the year 2025, StemCyte International had annual revenue of 368.91M, down -3.60%. That makes StemCyte International the 36,830th largest company in the world by revenue and 1,931st in Taiwan.

Revenue (ttm)
376.29M
Revenue Growth
-0.50%
P/S Ratio
7.31
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.75B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • United States 290.44M 78.7%
  • Taiwan 78.47M 21.3%

By Geography

Chart
  • United States 290.44M 78.7%
  • Taiwan 78.47M 21.3%
Fiscal year ended Dec 31, 2025 See the full StemCyte International breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025368.91M-13.77M-3.60%
Dec 31, 2024382.69M19.91M5.49%
Dec 31, 2023362.78M15.09M4.34%
Dec 31, 2022347.69M-509.38M-59.43%
Dec 31, 2013857.07M124.33M16.97%
Dec 31, 2012 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.